{"pmc": "11577515", "doi": "https://doi.org/10.12998/wjcc.v13.i1.99746", "title": "Lipomatous ependymoma with ZFTA: RELA fusion-positive: A case report", "Level1": "Chapter 2: Neoplasms", "Level2": "Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72)", "Rarity": 2, "Level2_Detail": "C69 Malignant neoplasm of eye and adnexa; C70 Malignant neoplasm of meninges; C71 Malignant neoplasm of brain; C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system", "ICD-10": "C71 Malignant neoplasm of brain", "exam_creation": {"final_policy": {"scenario": "A previously healthy 15-year-old boy is brought to the emergency department after an unwitnessed generalized tonic–clonic seizure that lasted about six minutes. On arrival he is alert, afebrile, and hemodynamically stable. Neurologic examination is non-focal, and serum glucose, electrolytes, calcium, and complete blood count are within normal limits. A non-contrast head CT obtained in the emergency department shows no hemorrhage, mass effect, or hydrocephalus.", "mcqs": [{"stage": "Initial Assessment", "question": "Which of the following is the most appropriate next neuroimaging study to evaluate for a potential structural epileptogenic lesion in this stabilized adolescent with a first unprovoked seizure and a normal non-contrast head CT?", "options": {"A": "Brain MRI with and without gadolinium contrast", "B": "Rapid-sequence emergency MRI of the brain without contrast", "C": "Outpatient electroencephalography without additional neuroimaging", "D": "CT angiography of the head and neck", "E": "Repeat non-contrast head CT in 24 hours", "F": "CT perfusion of the brain", "G": "Contrast-enhanced MR angiography", "H": "Carotid duplex ultrasonography", "I": "Non-contrast MRI of the cervical spine", "J": "Whole-body 18F-FDG PET/CT"}, "correct_answer": "A"}, {"stage": "Diagnostic Workup", "question": "Brain MRI with and without gadolinium demonstrates a well-circumscribed 2.0 × 1.5 × 1.9 cm periventricular mass in the right parieto-occipital region abutting the atrium of the lateral ventricle. The lesion is predominantly cystic with a small enhancing mural nodule, contains coarse internal calcification, and is associated with minimal surrounding edema. Which of the following is the MOST likely diagnosis?", "options": {"A": "Supratentorial ependymoma", "B": "Dysembryoplastic neuroepithelial tumor", "C": "Pleomorphic xanthoastrocytoma", "D": "Ganglioglioma", "E": "Angiocentric glioma", "F": "Oligodendroglioma", "G": "Cavernous malformation", "H": "Pilocytic astrocytoma", "I": "Arachnoid cyst", "J": "Epidermoid cyst"}, "correct_answer": "A"}, {"stage": "Pathology Evaluation", "question": "The lesion is completely excised. Hematoxylin–eosin–stained sections are shown in Figure 2. Which histopathologic feature highlighted in Figure 2 is MOST characteristic of this tumor?", "options": {"A": "Perivascular pseudorosettes", "B": "Rosenthal fibers", "C": "Homer Wright rosettes", "D": "Psammoma bodies", "E": "Verocay bodies", "F": "Schiller–Duval bodies", "G": "Call–Exner bodies", "H": "Palisading necrosis", "I": "Onion-bulb formations", "J": "Pick bodies"}, "correct_answer": "A", "image_details": [{"label": null, "caption": "Histopathological findings. A: The tissue boundary in the cystic wall-like structure was clear [hematoxylin and eosin (HE) × 40]; B: Calcifications were seen on the cyst wall (HE × 100); C: Large vacuoles were seen in the cytoplasm of tumor cells on the cyst wall (HE × 400); D: Characteristic perivascular pseudorosettes (HE × 200); E: Vascular endothelial cell proliferation was seen, resembling a glomerular structure (HE × 200); F: Vacuoles in the cytoplasm pushed the crescentic nucleus, similar to signet ring cells (HE × 1000).", "file": "99746-g002.jpg", "id": "F2", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd8f/11577515/bff7cea73457/99746-g002.jpg", "caption_prefix": "Figure 2", "type": "Histopathology"}]}, {"stage": "Immunohistochemistry Interpretation", "question": "Immunostains are shown in Figure 3. Which immunohistochemical profile best corresponds to the tumor demonstrated?", "options": {"A": "Glial fibrillary acidic protein (GFAP) positive; punctate (dot-like) epithelial membrane antigen (EMA) positive; cytokeratin negative", "B": "Synaptophysin positive; NeuN positive; GFAP negative", "C": "Cytokeratin positive; EMA diffuse membranous positive; GFAP negative", "D": "S-100 negative; GFAP negative; Olig-2 strong positive", "E": "GFAP negative; STAT6 nuclear positive; EMA negative", "F": "Chromogranin A positive; Synaptophysin positive; Ki-67 >25%", "G": "EMA negative; somatostatin receptor 2 strong membranous positive; vimentin positive", "H": "IDH1 R132H positive; ATRX loss; p53 overexpression", "I": "ALK-1 positive; desmin positive; MyoD1 positive", "J": "BCL-2 positive; CD99 positive; FLI-1 positive"}, "correct_answer": "A", "image_details": [{"label": null, "caption": "Immunohistochemistry findings. A: The tumor cells were positive for GFAP [Immunohistochemistry (IHC) × 400]; B: Individual cells were positive for Olig-2 (IHC × 200); C: Significant punctate intracytoplasmic EMA immunoreactivity was observed (IHC × 400); D: The Ki-67 proliferation index was about 5% (IHC × 400).", "file": "99746-g003.jpg", "id": "F3", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd8f/11577515/416822cfde05/99746-g003.jpg", "caption_prefix": "Figure 3", "type": "Histopathology"}]}, {"stage": "Molecular Analysis", "question": "Based on the targeted RNA-sequencing read-alignment plot shown in Figure 4, which of the following gene fusions is present in this tumor?", "options": {"A": "ZFTA–RELA", "B": "KIAA1549–BRAF", "C": "EWSR1–FLI1", "D": "MYB–QKI", "E": "BCR–ABL1", "F": "ETV6–NTRK3", "G": "FGFR3–TACC3", "H": "TPM3–ALK", "I": "YAP1–MAMLD1", "J": "FUS–DDIT3"}, "correct_answer": "A", "image_details": [{"label": null, "caption": "Genetic analysis revealed ZFTA: RELA fusion.", "file": "99746-g004.jpg", "id": "F4", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd8f/11577515/46a50af34511/99746-g004.jpg", "caption_prefix": "Figure 4", "type": "Statistical Plot"}]}], "scenario_image_details": [], "scenario_table_details": []}}}
{"pmc": "11606362", "doi": "https://doi.org/10.12998/wjcc.v13.i5.100158", "title": "Nasal cavity fungus ball discovered accidentally: A case report", "Level1": "Chapter 10: Diseases of the respiratory system", "Level2": "Acute and Chronic Respiratory Infections and Disorders (J00-J06; J09-J18; J20-J22; J30-J39)", "Rarity": 2, "Level2_Detail": "J00 Acute nasopharyngitis [common cold]; J01 Acute sinusitis; J02 Acute pharyngitis; J03 Acute tonsillitis; J04 Acute laryngitis and tracheitis; J05 Acute obstructive laryngitis [croup] and epiglottitis; J06 Acute upper respiratory infections of multiple and unspecified sites; J09 Influenza due to certain identified influenza virus; J10 Influenza due to identified seasonal influenza virus; J11 Influenza, virus not identified; J12 Viral pneumonia, not elsewhere classified; J13 Pneumonia due to Streptococcus pneumoniae; J14 Pneumonia due to Haemophilus influenzae; J15 Bacterial pneumonia, not elsewhere classified; J16 Pneumonia due to other infectious organisms, not elsewhere classified; J17* Pneumonia in diseases classified elsewhere; J18 Pneumonia, organism unspecified; J20 Acute bronchitis; J21 Acute bronchiolitis; J22 Unspecified acute lower respiratory infection; J30 Vasomotor and allergic rhinitis; J31 Chronic rhinitis, nasopharyngitis and pharyngitis; J32 Chronic sinusitis; J33 Nasal polyp; J34 Other disorders of nose and nasal sinuses; J35 Chronic diseases of tonsils and adenoids; J36 Peritonsillar abscess; J37 Chronic laryngitis and laryngotracheitis; J38 Diseases of vocal cords and larynx, not elsewhere classified; J39 Other diseases of upper respiratory tract", "ICD-10": "J34 Other disorders of nose and nasal sinuses", "exam_creation": {"final_policy": {"scenario": "A 71-year-old man with metastatic lung adenocarcinoma undergoes routine surveillance brain MRI. The radiologist notes an unexpected soft-tissue density in the posterior right nasal cavity. The patient is immunocompetent and denies nasal obstruction, discharge, facial pain, epistaxis, prior nasal surgery, or trauma. He is referred to the otolaryngology clinic for evaluation.", "mcqs": [{"stage": "Initial Assessment", "question": "Rigid nasal endoscopy is performed (Figure 1). Based on the endoscopic appearance, which of the following is the most likely diagnosis?", "options": {"A": "Non-invasive fungal ball (aspergilloma)", "B": "Rhinolith formed around an endogenous nidus", "C": "Retained synthetic foreign body with calcific encrustation", "D": "Allergic fungal rhinosinusitis with allergic mucin", "E": "Necrotizing invasive fungal rhinosinusitis", "F": "Actinomycotic concretion", "G": "Keratin debris from sinonasal cholesteatoma", "H": "Organized sinonasal hematoma", "I": "Extranodal NK/T-cell lymphoma, nasal type", "J": "Inverted papilloma"}, "correct_answer": "A", "image_details": [{"label": null, "caption": "Physical examination. A: A dark gray, cheese-like substance is observed behind the right inferior turbinate; B: This mass is attached to the floor of the nasal cavity.", "file": "100158-g001.jpg", "id": "F1", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e74a/11606362/2e54f270d75d/100158-g001.jpg", "caption_prefix": "Figure 1", "type": "Endoscopy"}]}, {"stage": "Radiologic Evaluation", "question": "Non-contrast CT of the paranasal sinuses is obtained (Figure 2). Which diagnosis best explains the bony abnormality in the right maxillary sinus?", "options": {"A": "Osteoma of the maxillary sinus", "B": "Paget disease involving the maxilla", "C": "Fibrous dysplasia of the maxilla", "D": "Cemento-ossifying fibroma", "E": "Low-grade central osteosarcoma", "F": "Adult-type ossifying fibroma", "G": "Chronic invasive fungal sinusitis with bony sclerosis", "H": "Osseous hemangioma", "I": "Juvenile ossifying fibroma", "J": "Odontogenic myxoma"}, "correct_answer": "C", "image_details": [{"label": null, "caption": "On computed tomography scan, a 2.8 cm-sized calcified lesion is observed posterior to the inferior turbinate of the right nasal cavity and fibrous dysplasia of the ipsilateral maxillary sinus.", "file": "100158-g002.jpg", "id": "F2", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e74a/11606362/f7ac172ec115/100158-g002.jpg", "caption_prefix": "Figure 2", "type": "CT Scan"}]}, {"stage": "Imaging Correlation", "question": "Magnetic resonance imaging of the nasal cavity lesion is obtained (Figure 3). Which entity most commonly demonstrates the signal characteristics seen in this case?", "options": {"A": "Non-invasive fungal ball (aspergilloma)", "B": "Calcified osteoma", "C": "Hemosiderin-rich sinonasal organized hematoma", "D": "Sinonasal melanoma", "E": "Ossifying fibroma with mature calcification", "F": "Sinonasal hemangiopericytoma (glomangiopericytoma)", "G": "Juvenile nasopharyngeal angiofibroma", "H": "Allergic fungal rhinosinusitis", "I": "Sinonasal lymphoma", "J": "Chondrosarcoma"}, "correct_answer": "A", "image_details": [{"label": null, "caption": "Weighted magnetic resonance imaging. A: An axial T1-weighted magnetic resonance imaging (MRI) shows an iso-intense signal lesion in the right nasal cavity; B: The hypo-intense signal intensity lesion on T2-weighted MRI.", "file": "100158-g003.jpg", "id": "F3", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e74a/11606362/3c2efa97f2d8/100158-g003.jpg", "caption_prefix": "Figure 3", "type": "MRI"}]}, {"stage": "Postoperative Management", "question": "The mass is completely excised endoscopically, and an intra-operative debridement leaves the cavity pristine. Histopathology confirms a non-invasive Aspergillus fungal ball confined to the nasal cavity. Which postoperative plan is most appropriate according to current evidence-based practice?", "options": {"A": "Saline irrigations only with first follow-up at 3 months", "B": "Saline irrigations plus a single endoscopic debridement at 2 weeks, then routine follow-up", "C": "Saline irrigations plus topical budesonide nasal irrigations for four weeks", "D": "Oral itraconazole 200 mg twice daily for six weeks", "E": "Oral voriconazole 200 mg twice daily for two weeks", "F": "Daily topical voriconazole nasal irrigations for six weeks", "G": "Saline irrigations plus systemic corticosteroid taper over four weeks", "H": "Wide surgical resection including inferior turbinate and medial maxillectomy", "I": "Intravenous liposomal amphotericin B for two weeks", "J": "Prophylactic broad-spectrum antibiotics for one month"}, "correct_answer": "B"}], "scenario_image_details": [], "scenario_table_details": []}}}
{"pmc": "11664618", "doi": "https://doi.org/10.4251/wjgo.v17.i1.100757", "title": "Targeted gene sequencing and bioinformatics analysis of patients with gallbladder neuroendocrine carcinoma: A case report", "Level1": "Chapter 2: Neoplasms", "Level2": "Malignant neoplasms of digestive organs (C15-C26)", "Rarity": 1, "Level2_Detail": "C15 Malignant neoplasm of esophagus; C16 Malignant neoplasm of stomach; C17 Malignant neoplasm of small intestine; C18 Malignant neoplasm of colon; C19 Malignant neoplasm of rectosigmoid junction; C20 Malignant neoplasm of rectum; C21 Malignant neoplasm of anus and anal canal; C22 Malignant neoplasm of liver and intrahepatic bile ducts; C23 Malignant neoplasm of gallbladder; C24 Malignant neoplasm of other and unspecified parts of biliary tract; C25 Malignant neoplasm of pancreas; C26 Malignant neoplasm of other and ill-defined digestive organs", "ICD-10": "C23 Malignant neoplasm of gallbladder", "exam_creation": {"final_policy": {"scenario": "A 73-year-old woman presents with one week of vague upper-abdominal discomfort. She denies weight loss, fever, jaundice, or night sweats. Vital signs are stable and physical examination is unremarkable.", "mcqs": [{"stage": "Imaging Evaluation", "question": "Figure 1 shows a contrast-enhanced CT of the upper abdomen obtained to evaluate her symptoms. From which anatomic structure does the mass most likely originate?", "options": {"A": "Gallbladder fundus", "B": "Pancreatic head", "C": "Segment VIII of the liver (intra-parenchymal)", "D": "Common bile duct", "E": "Right adrenal gland", "F": "Gastric antrum", "G": "Duodenal bulb", "H": "Upper pole of the right kidney", "I": "Hepatic flexure of the colon", "J": "Cystic duct remnant"}, "correct_answer": "A", "image_details": [{"label": null, "caption": "Abdominal contrast-enhanced computed tomography scan reveals a 7 cm mass in liver segments IVb and V, with localized thickening of the gallbladder fundus wall and early-stage enhancement followed by a prolonged contrast effect. A: Arterial phase showed inhomogeneous lesion enhancement; B: The portal venous phase showed a prolonged contrast effect in the mass; C: The delayed phase showed progressive enhancement of the mass; D: The mass invades liver segments IVb and V.", "file": "100757-g001.jpg", "id": "F1", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fadc/11664618/d09bd8e117aa/100757-g001.jpg", "caption_prefix": "Figure 1", "type": "CT Scan"}]}, {"stage": "Differential Diagnosis", "question": "Considering the clinical presentation and the CT findings in Figure 1, which of the following is the MOST likely primary diagnosis?", "options": {"A": "Intrahepatic cholangiocarcinoma", "B": "Gallbladder carcinoma with direct liver invasion", "C": "Hepatocellular carcinoma", "D": "Pancreatic adenocarcinoma", "E": "Mirizzi syndrome", "F": "Pyogenic liver abscess", "G": "Metastatic colorectal cancer to the liver", "H": "Cavernous hemangioma of the liver", "I": "Xanthogranulomatous cholecystitis", "J": "Biliary cystadenoma"}, "correct_answer": "B"}, {"stage": "Histopathologic Confirmation", "image_details": [{"label": null, "caption": "Pathological analysis results. A: Hematoxylin and eosin staining revealed a nest-like arrangement of tumor cells exhibiting marked cellular heterogeneity and visible necrosis; B–D: Immunohistochemical analyses showed positivity for chromogranin A, Ki-67, and synaptophysin, respectively.", "file": "100757-g004.jpg", "id": "F4", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fadc/11664618/676d731dd226/100757-g004.jpg", "caption_prefix": "Figure 4", "type": "Histopathology"}], "question": "After radical cholecystectomy, histopathological examination combined with the immunohistochemistry results shown in Figure 4 is obtained. Which tumor type is most consistent with these findings?", "options": {"A": "Moderately differentiated adenocarcinoma of the gallbladder", "B": "Cholangiocellular carcinoma", "C": "Well-differentiated neuroendocrine tumor (NET Grade 1)", "D": "Poorly differentiated large-cell neuroendocrine carcinoma", "E": "Metastatic small-cell carcinoma of pulmonary origin", "F": "Hepatoblastoma", "G": "Mucinous cystic neoplasm of the gallbladder", "H": "Clear-cell carcinoma", "I": "Lymphoepithelioma-like carcinoma", "J": "Sarcomatoid carcinoma"}, "correct_answer": "D"}, {"stage": "Postoperative Management", "question": "Pathology confirms a poorly differentiated neuroendocrine carcinoma with a Ki-67 index of 70%. Which systemic regimen is most appropriate as first-line adjuvant therapy for this patient?", "options": {"A": "Gemcitabine plus cisplatin", "B": "Cisplatin plus etoposide", "C": "FOLFOX (5-FU/leucovorin/oxaliplatin)", "D": "Sunitinib monotherapy", "E": "Everolimus", "F": "Sorafenib", "G": "Nivolumab monotherapy", "H": "Capecitabine alone", "I": "Leuprolide acetate", "J": "Chlorambucil"}, "correct_answer": "B"}], "scenario_image_details": [], "scenario_table_details": []}}}
{"pmc": "11670016", "doi": "https://doi.org/10.12998/wjcc.v13.i8.98320", "title": "Herpes simplex virus 2-induced aseptic meningitis presenting with sudden deafness: A case report", "Level1": "Chapter 1: Certain infectious and parasitic diseases", "Level2": "Viral Infections of the CNS, Arthropod-Borne, Skin, Hepatic, HIV, and Other Manifestations (A80-A89; A92-A99; B00-B09; B15-B34)", "Rarity": 1, "Level2_Detail": "A80 Acute poliomyelitis; A81 Atypical virus infections of central nervous system; A82 Rabies; A83 Mosquito-borne viral encephalitis; A84 Tick-borne viral encephalitis; A85 Other viral encephalitis, not elsewhere classified; A86 Unspecified viral encephalitis; A87 Viral meningitis; A88 Other viral infections of central nervous system, not elsewhere classified; A89 Unspecified viral infection of central nervous system; A92 Other mosquito-borne viral fevers; A93 Other arthropod-borne viral fevers, not elsewhere classified; A94 Unspecified arthropod-borne viral fever; A95 Yellow fever; A96 Arenaviral hemorrhagic fever; A97 Dengue fever; A98 Other viral hemorrhagic fevers, not elsewhere classified; A99 Unspecified viral hemorrhagic fever; B00 Herpesviral [herpes simplex] infections; B01 Varicella [chickenpox]; B02 Zoster [herpes zoster]; B03 Smallpox; B04 Monkeypox; B05 Measles; B06 Rubella [German measles]; B07 Viral warts; B08 Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified; B09 Unspecified viral infection characterized by skin and mucous membrane lesions; B15 Acute hepatitis A; B16 Acute hepatitis B; B17 Other acute viral hepatitis; B18 Chronic viral hepatitis; B19 Unspecified viral hepatitis; B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases; B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms; B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseases; B23 Human immunodeficiency virus [HIV] disease resulting in other conditions; B24 Unspecified human immunodeficiency virus [HIV] disease; B25 Cytomegaloviral disease; B26 Mumps; B27 Infectious mononucleosis; B30 Viral conjunctivitis; B33 Other viral diseases, not elsewhere classified; B34 Viral infection of unspecified site", "ICD-10": "A87 Viral meningitis", "exam_creation": {"final_policy": {"scenario": "A 68-year-old man presents with a 24-hour history of sudden, profound hearing loss in his left ear accompanied by a sensation of fullness. He denies vertigo, tinnitus, headache, recent upper-respiratory infection, medication changes, or trauma. Past medical history includes type 2 diabetes mellitus, hypertension, and a kidney transplant in 2013; he takes tacrolimus. Vital signs are stable. Otoscopic examination reveals normal external auditory canals and intact tympanic membranes. Bedside tuning-fork testing localises sound to the right ear on Weber and shows air > bone conduction bilaterally on Rinne, suggesting left-sided sensorineural hearing loss.", "mcqs": [{"stage": "Initial Therapeutic Decision", "question": "Pure-tone audiometry performed within 24 hours confirms an 80–90 dB sensorineural loss in the left ear with normal thresholds on the right. The patient is able to swallow medications and has no gastrointestinal comorbidity. According to current guideline-based management of sudden sensorineural hearing loss, which of the following is the most appropriate first-line therapy to initiate within the first 72 hours?", "options": {"A": "High-dose oral prednisone 1 mg/kg/day (maximum 60 mg) once daily in the morning for 3 days; if effective, continue for 2 more days and then stop without taper", "B": "High-dose intravenous methylprednisolone 250 mg/day for 3 days followed by taper", "C": "Oral prednisone 60 mg daily plus oral valacyclovir 1 g three times daily", "D": "Oral valacyclovir 1 g three times daily as monotherapy", "E": "Intratympanic dexamethasone injection alone", "F": "Primary hyperbaric oxygen therapy without steroids", "G": "Low-salt diet with oral thiazide diuretic", "H": "Immediate cochlear implantation", "I": "Observation only, with no pharmacologic intervention", "J": "Intratympanic gentamicin injection to the affected ear"}, "correct_answer": "A"}, {"stage": "Early Follow-Up (Day 6)", "question": "After 6 days of high-dose oral prednisone, repeat audiometry shows only minimal improvement (threshold 72 dB). The patient now has marked hyperglycaemia and mood lability attributed to systemic steroids. Which of the following is the most appropriate next (salvage) step to attempt further auditory recovery?", "options": {"A": "Intratympanic corticosteroid injections to the left ear", "B": "Intratympanic corticosteroid injections combined with hyperbaric oxygen therapy", "C": "Continue the same dose of oral prednisone for another 7 days", "D": "Escalate to intravenous methylprednisolone \"pulse\" therapy", "E": "Begin oral valacyclovir 1 g three times daily as sole therapy", "F": "Start daily aspirin 325 mg for presumed vascular aetiology", "G": "Initiate low-salt diet plus hydrochlorothiazide for suspected endolymphatic hydrops", "H": "Proceed directly to cochlear implantation", "I": "Administer intratympanic gentamicin to ablate vestibular function", "J": "Begin carbamazepine for presumed neuropathic pain"}, "correct_answer": "A"}, {"stage": "Acute Neurologic Deterioration (Week 3)", "question": "Two weeks after discharge, the patient returns with sudden confusion, left-sided weakness, tremor of all four limbs, and conjugate gaze deviation. Blood pressure is 255/217 mm Hg and serum glucose is 457 mg/dL. Non-contrast CT and MRI of the brain show no haemorrhage or acute infarct. After stabilisation of blood pressure and glucose, which diagnostic study is MOST likely to reveal the underlying aetiology of his persistent limb fasciculations and seizures?", "options": {"A": "Lumbar puncture with cerebrospinal fluid analysis", "B": "Continuous electroencephalography (EEG) monitoring", "C": "CT angiography of the head and neck", "D": "Carotid duplex ultrasonography", "E": "Serum ammonia concentration", "F": "Repeat diffusion-weighted MRI of the brain in 6 hours", "G": "Transthoracic echocardiography", "H": "Serum heavy-metal screening panel", "I": "Comprehensive antinuclear antibody profile", "J": "Colonoscopy"}, "correct_answer": "A"}, {"stage": "Definitive Therapy", "question": "Cerebrospinal fluid polymerase-chain-reaction testing returns positive for herpes simplex virus type 2. What is the most appropriate pharmacologic treatment at this point?", "options": {"A": "Intravenous acyclovir 10 mg/kg every 8 hours", "B": "Intravenous acyclovir 5 mg/kg every 24 hours", "C": "High-dose oral valacyclovir 1 g three times daily", "D": "Intravenous foscarnet 90 mg/kg every 12 hours", "E": "High-dose oral prednisone taper over 2 weeks", "F": "Intravenous ceftriaxone 2 g every 12 hours", "G": "Intravenous vancomycin 1 g every 12 hours", "H": "Oral amoxicillin-clavulanate 875/125 mg twice daily", "I": "Intravenous amphotericin B 0.7 mg/kg daily", "J": "Oral oseltamivir 75 mg twice daily"}, "correct_answer": "A"}, {"stage": "Risk Factor Analysis", "question": "Which of the following represents the MOST significant ongoing predisposing factor for this patient’s development of HSV-2 meningitis?", "options": {"A": "Chronic calcineurin-inhibitor immunosuppression following renal transplantation", "B": "Poor glycaemic control associated with type 2 diabetes mellitus", "C": "Recent 6-day course of high-dose systemic steroids", "D": "Age greater than 65 years", "E": "Male sex", "F": "Well-controlled hypertension", "G": "Remote childhood varicella infection", "H": "Seasonal allergic rhinitis", "I": "Mild hyperlipidaemia", "J": "History of unilateral sudden sensorineural hearing loss"}, "correct_answer": "A"}], "scenario_image_details": [], "scenario_table_details": []}}}
{"pmc": "11670020", "doi": "https://doi.org/10.12998/wjcc.v13.i9.96897", "title": "Pulmonary artery stent thrombosis and symptomatic pulmonary hypertension following COVID-19 infection in Alagille patient: A case report", "Level1": "Chapter 9: Diseases of the circulatory system", "Level2": "Pulmonary heart disease and diseases of pulmonary circulation (I26-I28)", "Rarity": 1, "Level2_Detail": "I26 Pulmonary embolism; I27 Other pulmonary heart diseases; I28 Other diseases of pulmonary vessels", "ICD-10": "I27 Other pulmonary heart diseases", "exam_creation": {"final_policy": {"scenario": "A 34-year-old woman presents to the emergency department with 5 days of progressive shortness of breath and sharp left-sided chest discomfort that worsens on inspiration. One month earlier she had a mild, fully resolved COVID-19 infection. Her history includes repaired congenital heart disease and placement of a stent in the left pulmonary artery (LPA) at age 15 for residual stenosis; she has been asymptomatic and physically active since. On arrival: T 36.8 °C, BP 118/72 mm Hg, HR 92 beats/min, RR 18 breaths/min, SpO₂ 93 % on room air. Lung fields are clear and the cardiac examination is unremarkable. A contrast-enhanced CT angiogram of the chest is obtained (Figure 1A).", "mcqs": [{"stage": "Initial Assessment", "question": "Based on Figure 1A and the clinical presentation, which diagnosis most plausibly explains the patient’s acute dyspnoea?", "options": {"A": "Acute thrombosis of the pre-existing left pulmonary artery stent", "B": "Fresh saddle pulmonary embolus straddling the main pulmonary bifurcation", "C": "Acute segmental pulmonary embolism in the right lower lobe branches", "D": "In-situ thrombosis of a right pulmonary artery branch unrelated to the stent", "E": "Early post-COVID organising pneumonia", "F": "Diffuse alveolar haemorrhage secondary to vasculitis", "G": "Spontaneous pneumomediastinum with secondary dyspnoea", "H": "Type B aortic dissection with pleural effusion", "I": "Large pericardial effusion causing tamponade physiology", "J": "Tension pneumothorax of the left hemithorax"}, "correct_answer": "A"}, {"stage": "Hemodynamic Characterisation", "question": "Right-heart catheterisation shows: mean pulmonary artery pressure 62 mm Hg, pulmonary capillary wedge pressure 14 mm Hg, pulmonary vascular resistance 20 Wood units. In this clinical context, which WHO classification of pulmonary hypertension is most appropriate?", "options": {"A": "WHO Group 1: Idiopathic pulmonary arterial hypertension", "B": "WHO Group 2: Pulmonary hypertension due to left-sided heart disease", "C": "WHO Group 3: Pulmonary hypertension secondary to post-COVID fibrotic lung disease", "D": "WHO Group 4: Chronic thrombo-embolic or other pulmonary artery obstruction", "E": "WHO Group 5: Pulmonary hypertension with multifactorial mechanisms (e.g., sarcoidosis)", "F": "Combined pre- and post-capillary pulmonary hypertension", "G": "High-output pulmonary hypertension from systemic-to-pulmonary shunt", "H": "Pulmonary veno-occlusive disease", "I": "Pulmonary hypertension associated with portal hypertension", "J": "Pulmonary hypertension in congenital cyanotic heart disease after Fontan surgery"}, "correct_answer": "D"}, {"stage": "Acute Interventional Decision", "question": "Selective pulmonary angiography (Figure 1E) demonstrates markedly reduced flow beyond the LPA stent. Which interventional strategy is the most appropriate immediate next step to attempt to restore perfusion?", "options": {"A": "Catheter-directed thrombolysis to the occluded left pulmonary artery segment", "B": "Immediate surgical pulmonary endarterectomy under deep hypothermic circulatory arrest", "C": "Percutaneous balloon pulmonary angioplasty of segmental branches alone", "D": "Initiate dual-oral pulmonary vasodilator therapy without further intervention", "E": "Mechanical aspiration thrombectomy using a large-bore catheter", "F": "High-dose intravenous corticosteroids for suspected vasculitis", "G": "Placement of an inferior vena cava filter without changing anticoagulation", "H": "Empiric broad-spectrum antibiotic therapy for presumed septic emboli", "I": "Observation on oral anticoagulation only", "J": "Early referral for combined heart–lung transplantation during this admission"}, "correct_answer": "A"}, {"stage": "Long-Term Planning", "question": "Three months later, repeat angiography (Figure 1F) shows complete occlusion distal to the fractured stent despite prior catheter-directed thrombolysis and balloon dilatation. She remains markedly exercise-limited and requires supplemental oxygen. She has been anticoagulated, could not tolerate maximal riociguat because of severe rash, and previously failed sildenafil and macitentan. What is the most appropriate next step in her long-term management?", "options": {"A": "Refer for formal evaluation for lung or heart–lung transplantation", "B": "Schedule staged series of balloon pulmonary angioplasty procedures to the occluded left pulmonary artery", "C": "Re-challenge with high-dose riociguat despite prior intolerance", "D": "Add warfarin to apixaban for dual anticoagulation", "E": "Implant a prophylactic inferior vena cava filter", "F": "Begin prolonged course of high-dose oral prednisone for presumed organising pneumonitis", "G": "Attempt surgical pulmonary endarterectomy of the distal stented segment", "H": "Initiate chronic ambulatory extracorporeal membrane oxygenation as bridge-to-decision", "I": "Enroll in pulmonary rehabilitation alone without additional therapy", "J": "Perform bronchial thermoplasty to improve airflow"}, "correct_answer": "A"}], "scenario_image_details": [{"label": null, "caption": "Imaging examinations of the patient. A: Axial view; B: Sagittal view of a chest computerized tomography (CT) with contrast, mediastinal window, showing lack of propagation of contrast material in the left lower lobe branch of the left pulmonary artery; C: Axial view of a chest CT with contrast, lung window, lower lobe view, demonstrating a widened blood vessel in the right lower lung and ground glass opacities throughout; D: Axial view of a chest CT with contrast, lung window, upper lobe view, demonstrating a widened blood vessel in the right lower lung and mosaicism of lung parenchyma; E: Right heart catheterization (October 2022) showing contrast propagation through 3 arteries distal to the left pulmonary artery stent; F: Right heart catheterization (February 2023) showing complete occlusion of the arteries distal to the fractured and thrombosed stent in the left pulmonary artery; G and H: Axial view of a high-resolution chest CT, November 2022, ground-glass opacities and mosaicism bilaterally.", "file": "96897-g001.jpg", "id": "F1", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f64/11670020/aff67f689e5a/96897-g001.jpg", "caption_prefix": "Figure 1", "type": "CT Scan; Computed Tomography Angiography (CTA); Angiography"}], "scenario_table_details": []}}}
{"pmc": "11670022", "doi": "https://doi.org/10.12998/wjcc.v13.i9.101363", "title": "Ulcerative colitis and bullous pemphigoid: Direct association or a medication side effect: A case report", "Level1": "Chapter 12: Diseases of the skin and subcutaneous tissue", "Level2": "Infectious, Bullous, and Eczematous Skin Disorders (L00-L30)", "Rarity": 1, "Level2_Detail": "L00 Staphylococcal scalded skin syndrome; L01 Impetigo; L02 Cutaneous abscess, furuncle and carbuncle; L03 Cellulitis; L04 Acute lymphadenitis; L05 Pilonidal cyst; L08 Other local infections of skin and subcutaneous tissue; L10 Pemphigus; L11 Other acantholytic disorders; L12 Pemphigoid; L13 Other bullous disorders; L14* Bullous disorders in diseases classified elsewhere; L20 Atopic dermatitis; L21 Seborrhoeic dermatitis; L22 Diaper [napkin] dermatitis; L23 Allergic contact dermatitis; L24 Irritant contact dermatitis; L25 Unspecified contact dermatitis; L26 Exfoliative dermatitis; L27 Dermatitis due to substances taken internally; L28 Lichen simplex chronicus and prurigo; L29 Pruritus; L30 Other dermatitis", "ICD-10": "L12 Pemphigoid", "exam_creation": {"final_policy": {"scenario": "A 38-year-old man with a 4-year history of ulcerative colitis limited to the colon presents to the clinic because of a 1-week history of intensely pruritic skin lesions that began on his trunk and have spread to his extremities. He reports mild left-sided abdominal discomfort and 1–2 loose, occasionally blood-streaked bowel movements per day. He has been taking oral mesalamine 4 g daily without interruption for the past year and is otherwise healthy. Vital signs are normal. Physical examination reveals multiple erythematous plaques studded with tense vesicles and bullae on the abdomen, arms, and legs. Figure 1 shows a photograph of his skin at presentation.", "mcqs": [{"stage": "Initial Assessment", "question": "Based on the clinical presentation and the photograph in Figure 1, which of the following is the most likely diagnosis?", "options": {"A": "Bullous pemphigoid", "B": "Dermatitis herpetiformis", "C": "Linear IgA bullous dermatosis", "D": "Pemphigus vulgaris", "E": "Stevens–Johnson syndrome", "F": "Erythema multiforme major", "G": "Guttate psoriasis", "H": "Drug-induced bullous fixed-drug eruption", "I": "Erythema nodosum", "J": "Pyoderma gangrenosum"}, "correct_answer": "A"}, {"stage": "Diagnostic Workup", "question": "Which of the following is the most appropriate next diagnostic test to confirm the suspected skin disorder in this patient?", "options": {"A": "Serum anti-endomysial IgA antibody assay", "B": "Skin prick testing for immediate hypersensitivity", "C": "Punch biopsy of lesional and perilesional skin with direct immunofluorescence", "D": "Patch testing for contact dermatitis", "E": "Colonoscopy with biopsy of colonic mucosa", "F": "ELISA for desmoglein-3 autoantibodies", "G": "Oral drug provocation test with mesalamine", "H": "PCR testing of blister fluid for herpes simplex virus", "I": "Quantitative plasma porphyrin levels", "J": "Peripheral blood cultures for bacteremia"}, "correct_answer": "C"}, {"stage": "Pathology Correlation", "question": "Histopathology reveals a subepidermal blister with many eosinophils, and direct immunofluorescence shows linear IgG and C3 deposition along the basement membrane. Autoantibodies in this condition most commonly target which of the following antigens?", "options": {"A": "Desmoglein 1", "B": "Desmoglein 3", "C": "Type VII collagen", "D": "BP180 (type XVII collagen)", "E": "Epidermal transglutaminase", "F": "Laminin-332", "G": "Collagen IV", "H": "Plectin", "I": "Keratin 14", "J": "Integrin α6β4"}, "correct_answer": "D"}, {"stage": "Initial Treatment", "question": "The patient has widespread, symptomatic skin involvement. Which of the following is the most appropriate initial systemic therapy?", "options": {"A": "Oral prednisone 0.5–1 mg/kg daily", "B": "Dapsone 100 mg daily", "C": "High-dose intravenous cyclophosphamide", "D": "Low-dose weekly methotrexate monotherapy", "E": "Mycophenolate mofetil 1 g twice daily as sole therapy", "F": "Topical tacrolimus ointment to affected areas only", "G": "Acitretin 25 mg daily", "H": "Rituximab 1 g intravenous infusion now and in 2 weeks", "I": "Azathioprine 50 mg daily as monotherapy", "J": "Narrow-band UVB phototherapy three times weekly"}, "correct_answer": "A"}, {"stage": "Follow-Up Management", "question": "After 3 weeks of oral prednisone 20 mg daily his skin clears, but the eruption recurs when the dose is tapered to 10 mg daily. Which of the following is the most appropriate next step in management?", "options": {"A": "Increase prednisone back to 20 mg daily and add a steroid-sparing immunosuppressive agent such as azathioprine", "B": "Maintain prednisone at 10 mg daily and add topical clobetasol only", "C": "Discontinue prednisone and start broad-spectrum antibiotics for presumed superinfection", "D": "Switch from prednisone to non-steroidal anti-inflammatory drugs for symptom control", "E": "Begin cyclosporine 5 mg/kg daily while stopping all steroids", "F": "Initiate intravenous immunoglobulin (IVIG) therapy without adjusting prednisone", "G": "Start phototherapy and discontinue systemic medications", "H": "Add ustekinumab while continuing the prednisone taper", "I": "Discontinue mesalamine immediately without altering prednisone dosing", "J": "Schedule urgent colectomy to eliminate the presumed antigen source"}, "correct_answer": "A"}], "scenario_image_details": [{"label": null, "caption": "Diffuse eruption of annular erythematous lesions and scattered tense blisters throughout the body.", "file": "101363-g001.jpg", "id": "F1", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9835/11670022/7f33da78dd0d/101363-g001.jpg", "caption_prefix": "Figure 1", "type": "Clinical Photograph"}], "scenario_table_details": []}}}
{"pmc": "11671844", "doi": "https://doi.org/10.5492/wjccm.v14.i1.97443", "title": "Thrombolysis and extracorporeal cardiopulmonary resuscitation for cardiac arrest due to pulmonary embolism: A case report", "Level1": "Chapter 9: Diseases of the circulatory system", "Level2": "Pulmonary heart disease and diseases of pulmonary circulation (I26-I28)", "Rarity": 2, "Level2_Detail": "I26 Pulmonary embolism; I27 Other pulmonary heart diseases; I28 Other diseases of pulmonary vessels", "ICD-10": "I26 Pulmonary embolism", "exam_creation": {"final_policy": {"scenario": "A 69-year-old man is being transported to the emergency department because of sudden-onset severe dyspnea. During transfer he becomes unresponsive; paramedics identify pulseless electrical activity and initiate manual cardiopulmonary resuscitation. Five minutes later he arrives in the resuscitation bay with ongoing chest compressions, an unsecured airway, and no palpable pulse.", "mcqs": [{"stage": "Initial Assessment", "question": "On arrival at the emergency department the patient remains in pulseless electrical activity while manual chest compressions continue. Which of the following is the most appropriate immediate next step in management?", "options": {"A": "Perform rapid-sequence endotracheal intubation to secure the airway", "B": "Deliver a synchronized 200-joule cardioversion shock", "C": "Obtain a contrast-enhanced computed tomography scan before further resuscitation", "D": "Administer 2 g intravenous magnesium sulfate", "E": "Start a propranolol infusion for rate control", "F": "Perform emergent pericardiocentesis", "G": "Give an intravenous nitroglycerin bolus", "H": "Insert a chest tube for presumed tension pneumothorax", "I": "Initiate therapeutic hypothermia at 33 °C immediately", "J": "Arrange urgent percutaneous coronary intervention"}, "correct_answer": "A"}, {"stage": "Diagnostic Workup", "question": "Despite advanced life support measures, spontaneous circulation has not returned, and an emergent contrast-enhanced computed tomography scan is obtained. Figure 1 (Panels A–D) shows the CT images. Based on these findings, which diagnosis most likely explains the patient’s hemodynamic collapse?", "options": {"A": "Massive pulmonary embolism", "B": "Acute anterior ST-segment elevation myocardial infarction with cardiogenic shock", "C": "Tension pneumothorax", "D": "Aortic dissection complicated by pericardial tamponade", "E": "Fulminant viral myocarditis", "F": "Severe community-acquired pneumonia with septic shock", "G": "Cardiac sarcoidosis causing ventricular arrhythmias", "H": "Acute hemorrhagic stroke with neurogenic pulmonary edema", "I": "Pulmonary edema secondary to acute severe mitral regurgitation", "J": "Air embolism from intravenous catheter placement"}, "correct_answer": "A", "image_details": [{"label": null, "caption": "Contrast-enhanced computed tomography findings. A: Thrombus in both pulmonary arteries (orange arrows); B: Extension to the distal right interlobar artery (orange arrow); C: Extension to the left interlobar pulmonary artery (orange arrow); D: Right ventricle dilation with a diameter of 46.6mm; E: Computed tomography showing left frontal lobe, parietal lobe and subarachnoid hemorrhage (orange arrows).", "file": "97443-g001.jpg", "id": "F1", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08a9/11671844/aeeb7eb43663/97443-g001.jpg", "caption_prefix": "Figure 1", "type": "CT Scan; Computed Tomography Angiography (CTA)"}]}, {"stage": "Emergency Therapy", "question": "The diagnosis of massive pulmonary embolism has been established while cardiopulmonary resuscitation continues. Which of the following represents the most appropriate immediate reperfusion strategy to pursue at this time?", "options": {"A": "Administer systemic tissue plasminogen activator (tPA) as a bolus followed by infusion", "B": "Begin low-dose unfractionated heparin infusion alone", "C": "Perform emergent percutaneous coronary intervention", "D": "Initiate an intravenous lidocaine infusion", "E": "Give high-dose furosemide for diuresis", "F": "Arrange urgent surgical pulmonary embolectomy under cardiopulmonary bypass", "G": "Insert an intra-aortic balloon pump", "H": "Undertake catheter-directed ultrasound-assisted thrombolysis in the interventional suite", "I": "Administer an intravenous calcium chloride bolus", "J": "Start oral rivaroxaban loading dose"}, "correct_answer": "A"}, {"stage": "Advanced Support", "question": "After 30 minutes of high-quality CPR and ongoing systemic thrombolysis, return of spontaneous circulation has not been achieved. Which of the following is the most appropriate next intervention?", "options": {"A": "Initiate veno-arterial extracorporeal membrane oxygenation (ECPR)", "B": "Terminate resuscitation efforts", "C": "Administer high-dose methylprednisolone", "D": "Insert a transvenous temporary pacemaker", "E": "Begin continuous sodium bicarbonate infusion", "F": "Perform emergency cricothyrotomy", "G": "Start surface cooling to 33 °C", "H": "Perform bilateral needle thoracostomy", "I": "Place a pulmonary artery catheter for hemodynamic monitoring", "J": "Institute high-dose insulin euglycemic therapy"}, "correct_answer": "A"}, {"stage": "Post-Resuscitation Complications", "question": "Several days later, after decannulation from extracorporeal support, the patient develops unequal pupils and remains comatose. A non-contrast head CT demonstrates a hyperdense intraparenchymal collection with surrounding edema and mass effect (Figure 1, Panel E). Which intracranial complication is most consistent with these imaging findings?", "options": {"A": "Intracerebral hemorrhage", "B": "Acute ischemic cerebral infarction", "C": "Subdural hygroma", "D": "Diffuse cerebral edema secondary to anoxic injury", "E": "Cerebral venous sinus thrombosis", "F": "Subfalcine herniation without primary bleed", "G": "Brain abscess", "H": "Epidural hematoma", "I": "Central pontine myelinolysis", "J": "Nonconvulsive status epilepticus"}, "correct_answer": "A"}], "scenario_image_details": [], "scenario_table_details": []}}}
{"pmc": "11695208", "doi": "https://doi.org/10.1002/ccr3.70060", "title": "Acute Transverse Myelitis as an Uncommon Presentation of Neurobrucellosis: A Case Report", "Level1": "Chapter 1: Certain infectious and parasitic diseases", "Level2": "Certain zoonotic bacterial diseases (A20-A28)", "Rarity": 2, "Level2_Detail": "A20 Plague; A21 Tularemia; A22 Anthrax; A23 Brucellosis; A24 Glanders and melioidosis; A25 Rat-bite fevers; A26 Erysipeloid; A27 Leptospirosis; A28 Other zoonotic bacterial diseases, not elsewhere classified", "ICD-10": "A23 Brucellosis", "exam_creation": {"final_policy": {"scenario": "A 69-year-old retired veterinarian from rural Greece arrives at the emergency department after suddenly developing profound weakness in both lower limbs over 4–5 h. He reports complete numbness below the waist and inability to void urine. There is no trauma or back pain. He regularly assists with livestock births and often eats unpasteurised goat cheese. Past medical history includes hypertension treated with perindopril and indapamide, and intermittent low-dose aspirin use. On examination he is afebrile, alert and oriented; power in both lower limbs is 0/5, tone is flaccid, reflexes are absent, all modalities of sensation are lost below the umbilicus, and a distended bladder is palpable.", "mcqs": [{"stage": "Initial Assessment", "question": "Which single investigation should be performed first to identify the cause of this patient’s acute spinal cord syndrome?", "options": {"A": "Magnetic resonance imaging of the entire spine with gadolinium contrast", "B": "Magnetic resonance imaging of the thoracolumbar spine without contrast", "C": "Urgent CT myelography of the thoracolumbar spine", "D": "Contrast-enhanced CT of the thoracolumbar spine", "E": "Non-contrast CT of the lumbosacral spine", "F": "Plain radiographs of the thoracolumbar spine", "G": "Electromyography and nerve-conduction studies", "H": "Magnetic resonance imaging of the brain only", "I": "Whole-body positron-emission tomography–CT", "J": "Radionuclide bone scan"}, "correct_answer": "A"}, {"stage": "Imaging Interpretation", "question": "Based on the clinical presentation and the MRI images provided in Figure 1, which of the following is the most likely diagnosis?", "options": {"A": "Acute transverse myelitis", "B": "Spinal epidural abscess", "C": "Metastatic spinal cord compression", "D": "Neuromyelitis optica spectrum disorder", "E": "Anterior spinal artery infarction", "F": "Intramedullary ependymoma", "G": "Spinal sarcoidosis", "H": "Spinal dural arteriovenous fistula", "I": "Cervical spondylotic myelopathy", "J": "Guillain–Barré syndrome"}, "correct_answer": "A", "image_details": [{"label": null, "caption": "MRI of the entire spine with gadolinium contrast. (A) Axial T2‐weighted image at the level of T11 demonstrating a hyperintense signal within the spinal cord, suggestive of inflammation and edema. (B) Sagittal T2‐weighted image shows hyperintense signal changes at the level of T10–T12 thoracic vertebrae, indicative of an inflammatory process without compressive lesions. These findings are consistent with transverse myelitis.", "file": "CCR3-13-e70060-g001.jpg", "id": "ccr370060-fig-0001", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac68/11695208/ef681f162991/CCR3-13-e70060-g001.jpg", "caption_prefix": "Figure 1", "type": "MRI"}]}, {"stage": "Advanced Diagnostics", "question": "Initial laboratory work-up shows leukocytosis with neutrophilia, markedly elevated C-reactive protein, and cerebrospinal fluid with neutrophilic pleocytosis, mildly elevated protein and normal glucose. GeneXpert testing for Mycobacterium tuberculosis is negative, and anti-aquaporin-4 as well as anti-MOG antibodies are absent. Considering his occupational exposure to livestock and frequent consumption of unpasteurised dairy products, which additional study would best help establish a specific infectious aetiology for his myelitis?", "options": {"A": "Serum VDRL and FTA-ABS tests", "B": "CSF PCR for varicella-zoster virus", "C": "CSF PCR for herpes simplex virus 1/2", "D": "Serum Lyme disease ELISA", "E": "Serum HIV-1 RNA quantitative PCR", "F": "CSF cryptococcal antigen assay", "G": "Serum HTLV-1 antibody screen", "H": "CSF JC virus PCR", "I": "Serum/CSF Leptospira PCR", "J": "CSF real-time PCR for Brucella species"}, "correct_answer": "J"}, {"stage": "Therapeutic Planning", "question": "Real-time PCR confirms Brucella infection of the central nervous system. Which of the following antibiotic regimens is the most appropriate initial therapy?", "options": {"A": "Doxycycline 100 mg orally twice daily plus rifampin 600 mg orally once daily plus ceftriaxone 2 g intravenously once daily for at least six weeks", "B": "Doxycycline 100 mg orally twice daily plus rifampin 600 mg orally once daily plus trimethoprim–sulfamethoxazole 160/800 mg orally twice daily for at least six weeks", "C": "Ceftriaxone 2 g intravenously once daily as monotherapy for four weeks", "D": "Doxycycline 100 mg orally twice daily alone for six weeks", "E": "Rifampin 600 mg orally once daily plus gentamicin 5 mg/kg/day intravenously for two weeks", "F": "Ampicillin–sulbactam 3 g intravenously every six hours for three weeks", "G": "Azithromycin 500 mg orally once daily for two weeks", "H": "Vancomycin 15 mg/kg intravenously every 12 h plus cefepime 2 g intravenously every 8 h for three weeks", "I": "High-dose intravenous methylprednisolone 1 g daily for five days without antimicrobial therapy", "J": "Liposomal amphotericin B 5 mg/kg/day intravenously for four weeks"}, "correct_answer": "A"}], "scenario_image_details": [], "scenario_table_details": []}}}
{"pmc": "11699825", "doi": "https://doi.org/10.1186/s13019-024-03222-8", "title": "Successful thoracoscopic-assisted resection of a functional paraganglioma in the mediastinum with extracorporeal circulation: a case report", "Level1": "Chapter 2: Neoplasms", "Level2": "Malignant neoplasms of thyroid and other endocrine glands (C73-C75)", "Rarity": 1, "Level2_Detail": "C73 Malignant neoplasm of thyroid gland; C74 Malignant neoplasm of adrenal gland; C75 Malignant neoplasm of other endocrine glands and related structures", "ICD-10": "C75 Malignant neoplasm of other endocrine glands and related structures", "exam_creation": {"final_policy": {"scenario": "A 16-year-old girl is referred for evaluation of poorly controlled hypertension that began one year ago. She reports episodic pounding headaches, palpitations, profuse sweating, nausea, and occasional vomiting. Blood-pressure logs from home show values as high as 210/100 mm Hg during symptomatic spells. Her family history is non-contributory, and she is taking no regular medications. On examination, she is thin, anxious-appearing, and afebrile. Blood pressure is 180/96 mm Hg in both arms, pulse 96 beats/min, and BMI 20 kg/m². Cardiopulmonary and abdominal examinations are unremarkable. Initial basic metabolic panel and complete blood count are normal.", "mcqs": [{"stage": "Initial Assessment", "question": "Which of the following is the most appropriate next diagnostic study to investigate a potential secondary cause of her paroxysmal hypertension given her symptom profile?", "options": {"A": "Twenty-four-hour urinary fractionated catecholamines and metanephrines", "B": "Plasma aldosterone-to-renin ratio", "C": "Overnight 1-mg dexamethasone suppression test", "D": "Renal artery Doppler ultrasound", "E": "Thyroid-stimulating hormone and free thyroxine levels", "F": "In-laboratory polysomnography", "G": "Serum creatinine and blood urea nitrogen", "H": "Midnight plasma free cortisol measurement", "I": "Transthoracic echocardiography", "J": "Ambulatory 24-hour blood-pressure monitoring"}, "correct_answer": "A"}, {"stage": "Diagnostic Workup", "question": "Results return and are summarised in Table 1. Based on the biochemical profile shown, which diagnosis best explains her clinical presentation?", "options": {"A": "Functional pheochromocytoma or paraganglioma", "B": "Cushing syndrome", "C": "Primary aldosteronism", "D": "Essential (primary) hypertension", "E": "Hyperthyroidism", "F": "Chronic kidney disease with secondary hypertension", "G": "Coarctation of the aorta", "H": "Liddle syndrome", "I": "Catecholamine-secreting neuroblastoma", "J": "Obstructive sleep apnoea"}, "correct_answer": "A", "table_details": [{"id": "Tab1", "caption": "Laboratory test results before the surgery", "content": "| Subject | First | Second |\n|---|---|---|\n| Urine VMA(≤ 60.24umol/day) | 145.5 | 157.95 |\n| Dopamine(≤ 195.7pmol/L) | 162.9 | 354.4 |\n| Adrenaline(≤ 605.4pmol/L) | 65.5 | 91.4 |\n| Norepinephrine(414-4435.5pmol/L) | 19005.7 | 35,732 |\n| 3-Methoxytyramine(<0.18nmol/L) | 0.10 | 0.34 |\n| Metanephrine(≤ 0.50nmol/L) | 0.09 | 0.22 |\n| Methoxy-norepinephrine(≤ 0.90nmol/L) | > 20.56 | 18.86 |", "caption_prefix": "Table 1", "type": "Laboratory Findings; Preoperative Assessment"}]}, {"stage": "Imaging Interpretation", "question": "Figure 2A shows a contrast-enhanced chest CT scan. In which mediastinal compartment is the mass primarily located?", "options": {"A": "Middle mediastinum", "B": "Anterior mediastinum", "C": "Posterior mediastinum", "D": "Superior mediastinum", "E": "Cervicomediastinal junction", "F": "Right pleural cavity", "G": "Intra-abdominal adrenal region", "H": "Right lower-lobe lung parenchyma", "I": "Left paravertebral gutter", "J": "Retrocrural space"}, "correct_answer": "A", "image_details": [{"label": null, "caption": "Imaging and pathological results of the patient. A) The chest CT with contrast shows a heterogeneous mass measuring 5.3 × 3.3 × 3.5 cm located just below the right pulmonary artery and above the pulmonary vein in the mediastinum. There is significant compression of the left atrium and downward displacement of the pulmonary vein. B) A follow-up contrast-enhanced CT at 6 months post-surgery reveals no signs of significant recurrence and no notable pleural or pericardial effusion. C) The MRI showed isointense to slightly hypointense T1 signals and slightly to highly hyperintense T2 signals in the immediate vicinity of the right upper pulmonary vein, right upper pulmonary artery, ascending aorta, esophagus, and left atrium. D) The gross specimen of the tumor measures 4.5 × 4.5 × 3 cm, with a grayish-yellow cross-section and a soft texture. E-F) Tumor cells predominantly exhibit a nested (Zellballen) and organoid arrangement, with focal necrosis and some involvement of myocardial tissue. Immunohistochemistry results: CD56 (+), Syn (+), CgA (+), S-100 (+), CK (-), Ki-67 (5% +). (CT: computed tomography, MRI: magnetic resonance imaging)", "file": "13019_2024_3222_Fig2_HTML.jpg", "id": "Fig2", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31f9/11699825/4665b150b39b/13019_2024_3222_Fig2_HTML.jpg", "caption_prefix": "Figure 2", "type": "CT Scan; MRI; Gross Pathology; Histopathology"}]}, {"stage": "Pre-operative Optimisation", "question": "After imaging confirms a functional catecholamine-secreting tumour in the middle mediastinum, which of the following peri-operative management strategies is most appropriate to minimise intra-operative haemodynamic instability?", "options": {"A": "Begin phenoxybenzamine with liberal salt and fluid intake 7–14 days before surgery", "B": "Start propranolol monotherapy immediately", "C": "Initiate continuous labetalol infusion without prior alpha blockade", "D": "Use hydralazine as needed for blood-pressure spikes only", "E": "Add an ACE inhibitor as the primary antihypertensive agent", "F": "Start spironolactone to control volume status", "G": "Prescribe a calcium-channel blocker alone for rate control", "H": "Proceed to urgent tumour resection without pharmacologic preparation", "I": "Place a renal-artery stent prior to surgery", "J": "Initiate high-dose loop diuretics to reduce preload"}, "correct_answer": "A"}, {"stage": "Intra-operative Planning", "question": "During surgery the mass is found to adhere to the posterior left atrial wall and right pulmonary vein. Which intra-operative adjunct is most likely to facilitate safe and complete tumour resection in this circumstance?", "options": {"A": "Cardiopulmonary bypass with femoral cannulation", "B": "Pre-operative external-beam radiotherapy", "C": "Endobronchial double-lumen intubation only", "D": "Low-pressure CO₂ insufflation to collapse the lung", "E": "Gamma-probe localisation of radiotracer uptake", "F": "Percutaneous radiofrequency ablation of the mass", "G": "Post-operative veno-venous extracorporeal membrane oxygenation", "H": "Insertion of an intra-aortic balloon pump before incision", "I": "Thoracic epidural anaesthesia as the sole anaesthetic technique", "J": "High-dose peri-operative corticosteroid therapy"}, "correct_answer": "A"}], "scenario_image_details": [], "scenario_table_details": []}}}
{"pmc": "11700400", "doi": "https://doi.org/10.1177/2050313X241311316", "title": "Non-fatal acute barium carbonate poisoning following suicidal ingestion: A case report", "Level1": "Chapter 19: Injury, poisoning and certain other consequences of external causes", "Level2": "Toxic effects of substances chiefly nonmedicinal as to source (T51-T65)", "Rarity": 1, "Level2_Detail": "T51 Toxic effect of alcohol; T52 Toxic effect of organic solvents; T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons; T54 Toxic effect of corrosive substances; T55 Toxic effect of soaps and detergents; T56 Toxic effect of metals; T57 Toxic effect of other inorganic substances; T58 Toxic effect of carbon monoxide; T59 Toxic effect of other gases, fumes and vapors; T60 Toxic effect of pesticides; T61 Toxic effect of noxious substances eaten as seafood; T62 Toxic effect of other noxious substances eaten as food; T63 Toxic effect of contact with venomous animals; T64 Toxic effect of aflatoxin and other mycotoxin food contaminants; T65 Toxic effect of other and unspecified substances", "ICD-10": "T56 Toxic effect of metals", "exam_creation": {"final_policy": {"scenario": "A 21-year-old college chemistry student (65 kg) is brought to the emergency department 2 hours after intentionally ingesting an unlabeled “industrial white powder” that he had purchased online as a laboratory rodenticide. He reports one episode of vomiting after drinking a glass of milk at home. On arrival he complains of nausea, burning epigastric pain, dizziness, and progressive weakness of both legs. Vital signs: temperature 36.7 °C, blood pressure 133/79 mm Hg, heart rate 48 beats / min, respiratory rate 20 breaths / min, oxygen saturation 98 % on room air. Neurologic examination shows generalized hypotonia and 4/5 strength in the lower extremities; cranial nerves and deep-tendon reflexes are otherwise normal. Arterial blood gas: pH 7.31, PaCO₂ 4.4 kPa (33 mm Hg), HCO₃⁻ 17 mmol/L. Serum sodium 138 mmol/L, chloride 103 mmol/L; the remainder of the chemistry panel (including potassium) is pending. A 12-lead ECG obtained on arrival is shown (Figure 1).", "mcqs": [{"stage": "Initial Assessment", "question": "Based on the clinical presentation and Figure 1 only, which single electrolyte disturbance best accounts for the bradycardia, muscular weakness, and ECG pattern observed?", "options": {"A": "Severe hypokalaemia (serum K+ < 2.5 mmol/L)", "B": "Moderate hypokalaemia (serum K+ 3.0–3.4 mmol/L)", "C": "Severe hyperkalaemia", "D": "Ionised hypocalcaemia", "E": "Ionised hypercalcaemia", "F": "Severe hypomagnesaemia", "G": "Hypermagnesaemia", "H": "Symptomatic hyponatraemia", "I": "Hypernatraemia", "J": "Primary metabolic acidosis without an electrolyte disorder"}, "correct_answer": "A"}, {"stage": "Diagnostic Workup", "question": "Seven hours after ingestion, the patient is more fatigued and a repeat chemistry panel shows serum potassium 1.8 mmol/L. A plain chest radiograph (Figure 3a) is obtained. Considering the new information, which ingested toxin most plausibly explains the imaging appearance, the profound hypokalaemia, and the clinical course?", "options": {"A": "Aluminium phosphide", "B": "Zinc phosphide", "C": "Sodium nitrite", "D": "Thallium sulfate", "E": "Arsenic trioxide", "F": "Lead shot ingestion", "G": "Paraquat dichloride", "H": "Sodium fluoroacetate", "I": "Digitalis glycosides", "J": "Barium carbonate"}, "correct_answer": "J", "image_details": [{"label": null, "caption": "Chest X-ray showing a large radiopaque mass in the stomach at 7 h (a), less dispersed radiopaque substances at 37 h post-ingestion (b), and absent at 66 h (c) post-ingestion.", "file": "10.1177_2050313X241311316-fig3.jpg", "id": "fig3-2050313X241311316", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a164/11700400/f75f33c45f46/10.1177_2050313X241311316-fig3.jpg", "caption_prefix": "Figure 3", "type": "X-ray; Radiography"}]}, {"stage": "Initial Gastrointestinal Management", "question": "Gastrointestinal decontamination is urgently planned to limit continued systemic absorption of the identified toxin. Which intervention is most appropriate at this time?", "options": {"A": "Gastric lavage with 2–5 % magnesium sulfate solution", "B": "Gastric lavage with room-temperature normal saline", "C": "Whole-bowel irrigation using polyethylene glycol only", "D": "Single dose of activated charcoal via nasogastric tube", "E": "Delayed activated charcoal 6 hours after ingestion", "F": "Induced emesis with ipecac syrup", "G": "Endoscopic retrieval of gastric contents without prior lavage", "H": "High-volume polyethylene glycol plus activated charcoal combination", "I": "Oral calcium carbonate antacid", "J": "Cathartic dose of castor oil"}, "correct_answer": "A"}, {"stage": "Ongoing Critical Care", "question": "Despite aggressive intravenous potassium chloride supplementation, the serum potassium falls further to 1.6 mmol/L at 9 hours post-ingestion. Which additional therapy is most appropriate now to both facilitate safe potassium repletion and enhance clearance of the circulating toxin?", "options": {"A": "High-dose regular insulin with dextrose infusion", "B": "Intravenous lipid emulsion (20 %) bolus and infusion", "C": "Exchange transfusion", "D": "Therapeutic plasmapheresis", "E": "Continuous venovenous haemodiafiltration", "F": "Intermittent haemodialysis without potassium supplementation", "G": "Urinary alkalinisation with intravenous sodium bicarbonate", "H": "High-dose intravenous corticosteroids", "I": "Hyperbaric oxygen therapy", "J": "Oral cholestyramine binding"}, "correct_answer": "E"}, {"stage": "Monitoring for Complications", "question": "Forty-two hours after ingestion, the creatine kinase level peaks at 2 647 U/L while serum creatinine remains within reference limits. Which complication best accounts for this isolated creatine kinase rise in the context of the poisoning?", "options": {"A": "Acute myocardial infarction", "B": "Exertional heat stroke", "C": "Statin-induced myopathy", "D": "Rhabdomyolysis secondary to toxin-induced skeletal muscle injury", "E": "Severe hypothyroidism", "G": "Autoimmune polymyositis", "H": "Malignant hyperthermia", "I": "Acute pancreatitis", "J": "Viral myositis"}, "correct_answer": "D"}], "scenario_image_details": [{"label": null, "caption": "Electrocardiogram showing sinus bradycardia (48 bpm), prolongation of QT interval, ST segment depression with U waves, and T wave inversion at 2 h post-ingestion.", "file": "10.1177_2050313X241311316-fig1.jpg", "id": "fig1-2050313X241311316", "url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a164/11700400/f4e8cd2c6706/10.1177_2050313X241311316-fig1.jpg", "caption_prefix": "Figure 1", "type": "Electrocardiography (ECG)"}], "scenario_table_details": []}}}
